Bayer CropScience will hold its AGM on August 19, 2026. Shareholders will vote on a ₹90 interim and ₹60 final dividend. Approval is also sought for material related party transactions up to ₹3,500 crore with Bayer AG.
Detailed Coverage
Bayer CropScience Schedules AGM, Proposes Dividends and Related Party Transactions
Bayer CropScience Limited has announced its 68th Annual General Meeting (AGM) will take place on Wednesday, August 19, 2026, conducted via video conferencing. **Reader Takeaway:** Shareholders to decide on ₹150 total dividend and a ₹3,500 crore RPT limit, reflecting continued operational reliance on the parent group. ## What just happened The company has set its AGM date and will present several key proposals to shareholders. These include the declaration of dividends for the financial year ended March 31, 2026, and seeking approval for significant related party transactions (RPTs) with its parent company, Bayer AG. ## Why this matters The AGM agenda is crucial for investors as it pertains to profit distribution and ongoing operational strategies. The proposed dividend payout of ₹150 per share (₹90 interim and ₹60 final) is a direct return to shareholders. The approval for a ₹3,500 crore RPT limit for FY 2027-28 with Bayer AG signifies the company's continued need for integration with its global parent for technology, research, and supply chain access. ## The backstory Bayer CropScience Limited operates as a subsidiary of the global Bayer Group. Related party transactions are a common and necessary feature of such structures, enabling the local entity to leverage the parent's expertise and resources. The proposed RPT limit is a forward-looking authorization, with past transactions in FY 2025-26 amounting to ₹1,598.2 crore. ## What changes now Shareholders will vote on these proposals at the AGM. Approval of the dividend will lead to its distribution. The authorization of the RPT limit will allow the company to continue its operational framework with Bayer AG for the specified period. Governance aspects, such as the re-appointment of a director and ratification of the cost auditor's fees, are also part of the agenda. ## Risks to watch While these are standard procedures, any significant deviation from historical RPT values or substantial increases in auditor fees could warrant closer investor scrutiny. The reliance on RPTs, although operational necessity, also highlights dependence on the parent group. ## Peer comparison Companies with similar multinational parentage often engage in related party transactions to access global R&D, intellectual property, and supply chains. The scale of Bayer CropScience's proposed RPT reflects its integration within the larger Bayer ecosystem. ## Context metrics (time-bound) * **Total Dividend Proposed (FY ended Mar 31, 2026):** ₹150 per equity share (₹90 interim + ₹60 final) * **Proposed RPT Limit (FY 2027-28):** ₹3,500 crore * **Actual RPT Value (FY 2025-26):** ₹1,598.2 crore * **AGM Date:** August 19, 2026 ## What to track next Investors should monitor the outcomes of the AGM, particularly the voting on the RPT proposals and dividend approval. Future financial reports will show the actual utilization of the RPT limit.
